US Stock MarketDetailed Quotes

Geron (GERN)

Watchlist
  • 1.370
  • +0.020+1.48%
Close Sep 14 15:59 ET
  • 1.369
  • -0.001-0.05%
Post 19:57 ET
880.19MMarket Cap-12.45P/E (TTM)

About Geron Company

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Company Profile

SymbolGERN
Company NameGeron
Listing DateJul 30, 1996
Issue Price8.00
ISINUS3741631036
Founded1990
CEOMr. Harout Semerjian
MarketNASDAQ
Employees258
Fiscal Year Ends12-31
Address919 East Hillsdale Boulevard,Suite 250
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-473-7700

Company Executives

  • Name
  • Position
  • Salary
  • Harout Semerjian
  • Director, President and Chief Executive Officer
  • 10.22M
  • Michelle J. Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.25M
  • Ahmed ElNawawi
  • Executive Vice President and Chief Commercial Officer
  • 2.88M
  • Dr. Joseph Emile Eid, M.D.
  • Executive Vice President, Research and Development
  • 1.00M
  • Elizabeth G. O’Farrell
  • Chairman of the Board and Lead Independent Director
  • 282.41K
  • Patricia S. Andrews
  • Director
  • --
  • Constantine Chinoporos
  • Director
  • --
  • Dawn Carter Bir
  • Independent Director
  • 522.12K
  • John F. McDonald
  • Independent Director
  • 231.80K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 233.67K
  • Dr. Robert Jay Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 226.17K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More